Combined docosahexaenoic acid and thyroid hormone supplementation as a protocol supporting energy supply to precondition and afford protection against metabolic stress situations-Reference-Cited by-同舟云学术

Combined docosahexaenoic acid and thyroid hormone supplementation as a protocol supporting energy supply to precondition and afford protection against metabolic stress situations

Published:2019-05-15 Issue:9 Volume:71 Page:1211-1220
ISSN:1521-6543
Container-title:IUBMB Life
language:en
Short-container-title:IUBMB Life

Author:

Videla Luis A.¹^ORCID

Affiliation:

1. Molecular and Clinical Pharmacology Program, Faculty of Medicine, Institute of Biomedical SciencesUniversity of Chile Santiago Chile

Funder

National Fund for Scientific & Technological Development

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Genetics,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/iub.2067

Reference124 articles.

1. Circadian Clock Control of Liver Metabolic Functions

2. Differentiation of amniotic epithelial cells into various liver cell types and potential therapeutic applications

3. Physiologic significance and regulation of hepatocellular heterogeneity

4. Oxidative stress signaling underlying liver disease and hepatoprotective mechanisms

5. Hepatic ischaemia–reperfusion injury from bench to bedside

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relevant Aspects of Combined Protocols for Prevention of N(M)AFLD and Other Non‐Communicable Diseases;Molecular Nutrition & Food Research;2024-03-20

2. Cellular Functional, Protective or Damaging Responses Associated with Different Redox Imbalance Intensities: A Comprehensive Review;Current Medicinal Chemistry;2023-10

3. Fish and the Thyroid: A Janus Bifrons Relationship Caused by Pollutants and the Omega-3 Polyunsaturated Fatty Acids;Frontiers in Endocrinology;2022-05-27

4. Perspectives in liver redox imbalance: Toxicological and pharmacological aspects underlying iron overloading, nonalcoholic fatty liver disease, and thyroid hormone action;BioFactors;2021-10-22

5. Targeting resolvins in cholestatic liver injury;Hepatobiliary Surgery and Nutrition;2021-10